Full-Time
Posted on 2/21/2025
Revenue cycle management solutions for healthcare
$15.45 - $24.29Hourly
Junior, Mid
Remote in USA
You match the following R1 RCM's candidate preferences
Employers are more likely to interview you if you match these preferences:
R1 RCM provides Revenue Cycle Management (RCM) solutions to healthcare providers, focusing on improving financial and administrative processes. The company uses technology and automation to streamline tasks such as patient registration, coding, billing, and collections, helping clients reduce costs and enhance patient satisfaction. Unlike its competitors, R1 RCM emphasizes reducing administrative burdens so healthcare providers can focus more on patient care. The goal is to partner with healthcare organizations to improve their financial performance and patient experiences.
Company Size
10,001+
Company Stage
IPO
Total Funding
N/A
Headquarters
Murray, Utah
Founded
2003
Help us improve and share your feedback! Did you find this helpful?
Performance Bonus
Professional Development Budget
EP Wealth Advisors LLC makes new $168,000 investment in R1 RCM Inc. (NASDAQ:RCM).
What You Should Know:– A new KLAS Research report examines the key drivers of client satisfaction in the physician advisory services market, highlighting the importance of accuracy, timeliness, strong relationships, and specialized service lines.– KLAS names Xsolis as a leader in overall client satisfaction among physician advisory services firms in helping healthcare providers navigate the complexities of regulatory and payer requirements.Key Drivers of Client SatisfactionThe report identifies several key factors that drive client satisfaction with physician advisory services:Accuracy: Providers value accurate and reliable determinations from physician advisors.Providers value accurate and reliable determinations from physician advisors. Timeliness: Prompt turnaround times for case reviews are essential for efficient workflows.Prompt turnaround times for case reviews are essential for efficient workflows. Clear Explanations: Providers appreciate clear, concise, and detailed explanations of determinations, which can be crucial for appeals if needed.Providers appreciate clear, concise, and detailed explanations of determinations, which can be crucial for appeals if needed. Strong Relationships: Building strong relationships and trust between providers and physician advisory firms is essential for effective collaboration.Report Key FindingsXsolis stands out for its high client satisfaction scores, particularly in the areas of accuracy, timeliness, and clear explanations. Clients praise the expertise of Xsolis’ physician advisors and the comprehensive documentation provided.The report also examines other leading physician advisory services firms, including R1 RCM, Brundage Medical Group, and Sound Physicians. Each firm has its own strengths and areas for improvement, highlighting the diverse landscape of this market.R1 RCM: Clients appreciate the comprehensive documentation and summaries provided by R1 RCM, but some report inconsistencies in turnaround times and accuracy, potentially due to high case volumes.Brundage Medical Group: Clients value the firm’s quick response rates and comprehensive explanations, which have led to positive outcomes like increased payer payments and improved CMS Star ratings
R1 RCM has been acquired by TowerBrook Capital Partners and Clayton, Dubilier & Rice in a deal valued at approximately $8.9 billion. The acquisition, announced on August 1, 2024, involved purchasing all outstanding shares at $14.30 per share in cash. Following the transaction, R1 RCM is now a private company and has ceased trading on Nasdaq. Joe Flanagan has returned as CEO, replacing Lee Rivas, to focus on operational excellence and technology leadership.
As HLTH 2024 prepares to convene in Las Vegas, the anticipation for groundbreaking insights and transformative discussions is palpable. To get a glimpse into the key themes and predictions shaping this year’s event, we reached out to 21 digital health executives for their expert perspectives.From the rise of generative AI and the evolving role of virtual care to the increasing focus on health equity and value-based care, these industry leaders offer a diverse range of perspectives on the most pressing challenges and promising opportunities facing the healthcare ecosystem.Join us as we delve into their predictions and explore the trends that are poised to redefine the future of healthcare at HLTH 2024.Ryne Natzke, chief revenue officer, TrustCommerce, a Sphere company, a provider of end-to-end integrated healthcare payments and security softwareAI, AI, and more AI! I’m looking forward to seeing how AI is being applied to help clinicians, patients, and other staff members provide better patient experiences and outcomes. Everything is moving so quickly that it will be exciting to get an update on where the industry is going.James Aita, director, Strategy and Business Development, Medicomp Systems, a physician-driven provider of diagnostically connected patient data solutionsOf course AI is the hot topic at HLTH this year–but with the new regulations from ASTP/ONC, the question is how can it be usable, trustworthy, transparent and helpful. I’m also interested in seeing who else is making AI and clinical data helpful at the point of care to reduce the burden on clinicians and inform patient care.Lyle Berkowitz, MD, CEO, KeyCare, the nation’s first Epic-based virtual care companyI always look forward to HLTH and seeing presentations of the newest cutting-edge technology and ideas. This year, I’m expecting deeper and wider use cases of AI to lead the charge. But in addition to technology innovations, I’m also hoping we will hear about other people and process topics such as how to set up virtual care teams and how to rethink primary care physician compensation to better align around adoption of automation and team-based care.Kazu Okuda, MD, CEO and co-founder of Universal Brain, whose platforms use brain-function measurement to drive precision psychiatryThe emergence of personalized treatment is an exciting field that I expect to take center stage at HLTH this year
Davidson Kempner Capital Management LP invests $6.53 million in R1 RCM Inc. (NASDAQ:RCM).